ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01812603
Recruitment Status : Completed
First Posted : March 18, 2013
Last Update Posted : August 11, 2016
Sponsor:
Information provided by (Responsible Party):
GW Research Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2015
  Actual Study Completion Date : June 2016